These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9406952)

  • 21. Release of endogenous 5-hydroxytryptamine in rat ventral hippocampus evoked by electrical stimulation of the dorsal raphe nucleus as detected by microdialysis: sensitivity to tetrodotoxin, calcium and calcium antagonists.
    Sharp T; Bramwell SR; Grahame-Smith DG
    Neuroscience; 1990; 39(3):629-37. PubMed ID: 2097517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Somatodendritic action of pindolol to attenuate the paroxetine-induced decrease in serotonin release from the rat ventral hippocampus: a microdialysis study.
    Míguez JM; Paz-Valiñas L; Míguez I; Aldegunde M
    Naunyn Schmiedebergs Arch Pharmacol; 2002 May; 365(5):378-87. PubMed ID: 12012024
    [TBL] [Abstract][Full Text] [Related]  

  • 23. L-DOPA elicits non-vesicular releases of serotonin and dopamine in hemiparkinsonian rats in vivo.
    Miguelez C; Navailles S; Delaville C; Marquis L; Lagière M; Benazzouz A; Ugedo L; De Deurwaerdère P
    Eur Neuropsychopharmacol; 2016 Aug; 26(8):1297-309. PubMed ID: 27234917
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Muscarinic antagonists in substantia nigra influence the decarboxylation of L-dopa in striatum.
    Izurieta-Sánchez P; Sarre S; Ebinger G; Michotte Y
    Eur J Pharmacol; 2000 Jul; 399(2-3):151-60. PubMed ID: 10884514
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The 5-HT1A receptor antagonist (S)-UH-301 augments the increase in extracellular concentrations of 5-HT in the frontal cortex produced by both acute and chronic treatment with citalopram.
    Arborelius L; Nomikos GG; Hertel P; Salmi P; Grillner P; Höök BB; Hacksell U; Svensson TH
    Naunyn Schmiedebergs Arch Pharmacol; 1996 May; 353(6):630-40. PubMed ID: 8738296
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential regulation of somatodendritic and nerve terminal dopamine release by serotonergic innervation of substantia nigra.
    Cobb WS; Abercrombie ED
    J Neurochem; 2003 Feb; 84(3):576-84. PubMed ID: 12558977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Utility of organotypic raphe slice cultures to investigate the effects of sustained exposure to selective 5-HT reuptake inhibitors on 5-HT release.
    Nagayasu K; Yatani Y; Kitaichi M; Kitagawa Y; Shirakawa H; Nakagawa T; Kaneko S
    Br J Pharmacol; 2010 Dec; 161(7):1527-41. PubMed ID: 20698856
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro and in vivo activity of 1-(1-naphthyl)piperazine at terminal 5-HT autoreceptors in guinea-pig brain.
    Moret C; Briley M
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Apr; 351(4):377-84. PubMed ID: 7630428
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of ion channel blockers on rapid postmortem changes in extracellular dopamine and serotonin levels in the rat nucleus accumbens.
    Yoshimoto K; Yayama K; Sorimachi Y; Tani J; Uemara K; Yoshida T; Ogata M; Nishimura A; Ueda S; Komura S
    Forensic Sci Int; 1997 Feb; 85(1):29-39. PubMed ID: 9050219
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The release of amino acids from rat neostriatum and substantia nigra in vivo: a dual microdialysis probe analysis.
    Bianchi L; Colivicchi MA; Bolam JP; Della Corte L
    Neuroscience; 1998 Nov; 87(1):171-80. PubMed ID: 9722150
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sibutramine induces potential-dependent exocytotic release but not carrier-mediated release of dopamine and 5-hydroxytryptamine.
    Ukai K; Nakagawa T; Ohyama T; Nakanishi H
    Eur J Pharmacol; 2004 Jan; 484(2-3):209-15. PubMed ID: 14744605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microdialysis study of the effects of the antiparkinsonian drug budipine on L-DOPA-induced release of dopamine and 5-hydroxytryptamine by rat substantia nigra and corpus striatum.
    Biggs CS; Starr MS
    Synapse; 1999 Oct; 34(1):36-46. PubMed ID: 10459170
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in extracellular levels of glutamate and aspartate in rat substantia nigra induced by dopamine receptor ligands: in vivo microdialysis studies.
    Abarca J; Gysling K; Roth RH; Bustos G
    Neurochem Res; 1995 Feb; 20(2):159-69. PubMed ID: 7783840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Electrical stimulation of the substantia nigra reticulata: detection of neuronal extracellular GABA in the ventromedial thalamus and its regulatory mechanism using microdialysis in awake rats.
    Timmerman W; Westerink BH
    Synapse; 1997 May; 26(1):62-71. PubMed ID: 9097406
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo mechanisms underlying dopamine release from rat nigrostriatal terminals: II. Studies using potassium and tyramine.
    Fairbrother IS; Arbuthnott GW; Kelly JS; Butcher SP
    J Neurochem; 1990 Jun; 54(6):1844-51. PubMed ID: 2338545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endogenous GABA potentiates the potassium-induced release of dopamine in striatum of the freely moving rat: a microdialysis study.
    Galindo A; Del Arco A; Mora F
    Brain Res Bull; 1999 Oct; 50(3):209-14. PubMed ID: 10566983
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of methylenedioxymethamphetamine-induced striatal dopamine release by the interaction between serotonin and gamma-aminobutyric acid in the substantia nigra.
    Yamamoto BK; Nash JF; Gudelsky GA
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1063-70. PubMed ID: 7791076
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of the in vivo release of dopamine as recorded by different types of intracerebral microdialysis probes.
    Santiago M; Westerink BH
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Oct; 342(4):407-14. PubMed ID: 1701521
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo mechanisms underlying dopamine release from rat nigrostriatal terminals: I. Studies using veratrine and ouabain.
    Fairbrother IS; Arbuthnott GW; Kelly JS; Butcher SP
    J Neurochem; 1990 Jun; 54(6):1834-43. PubMed ID: 2338544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo characterization of somatodendritic dopamine release in the substantia nigra of 6-hydroxydopamine-lesioned rats.
    Sarre S; Yuan H; Jonkers N; Van Hemelrijck A; Ebinger G; Michotte Y
    J Neurochem; 2004 Jul; 90(1):29-39. PubMed ID: 15198664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.